Concepedia

Coreen Oei

CO

6

Publications

463

Citations

6

H-Index

1996

Active since

Affiliations

Duke University Hospital(Current)

GlaxoSmithKline (United States)

Indiana University – Purdue University Indianapolis

Duke Medical Center

Research Triangle Park Foundation

Coreen Oei is an author at Duke University Hospital specializing in immunology, cancer research, and medicine.

Top concepts

Publications per year

1996–2018

6

Publications

6

Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer

Michael J. Robertson, James W. Mier, Theodore F. Logan et al. · Clinical Cancer Research · 2006 · 167 citations

A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial

Richard A. Brigandi, Brendan M. Johnson, Coreen Oei et al. · American Journal of Kidney Diseases · 2016 · 159 citations · Full text

Phase 2, multicenter study of the EZH2 inhibitor tazemetostat as monotherapy in adults with relapsed or refractory (R/R) malignant mesothelioma (MM) with BAP1 inactivation.

Marjorie G. Zauderer, Peter W. Szlosarek, Sylvestre Le Moulec et al. · Journal of Clinical Oncology · 2018 · 52 citations

, , +17

MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.

John Toso, Coreen Oei, Farshid Oshidari et al. · PubMed · 1996 · 51 citations

, , +21

Herpesvirus Saimiri Transformation of HIV Type 1 Suppressive CD8 <sup>+</sup> Lymphocytes from an HIV Type 1-Infected Asymptomatic Individual

Simon F. Lacey, Kent J. Weinhold, Chin‐Ho Chen et al. · AIDS Research and Human Retroviruses · 1998 · 23 citations

Rows per page

1–5 of 6